Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
  • Alerts
  • Subscriptions

Characterisation and impact of reported and unreported exacerbations: results from ATTAIN

Paul W. Jones, Rosa Lamarca, Ferran Chuecos, Dave Singh, Alvar Agustí, Eric D. Bateman, Gonzalo de Miquel, Cynthia Caracta, Esther Garcia Gil
European Respiratory Journal 2014; DOI: 10.1183/09031936.00038814
Paul W. Jones
1Division of Clinical Science, St George’s, University of London, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rosa Lamarca
2R&D Centre, Almirall, Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ferran Chuecos
2R&D Centre, Almirall, Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dave Singh
3Medicines Evaluation Unit, University Hospital of South Manchester, Manchester, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alvar Agustí
4Thorax Institute, Hospital Clinic, IDIBAPS, University of Barcelona, Barcelona, Spain
5FISIB, Centro de Investigación Biomédica en Red Enfermedades Respiratorias (CIBERES), Mallorca, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eric D. Bateman
6Dept of Medicine, University of Cape Town, Cape Town, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gonzalo de Miquel
2R&D Centre, Almirall, Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cynthia Caracta
7Forest Research Institute, Forest Laboratories Inc., Jersey City, NJ, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Esther Garcia Gil
2R&D Centre, Almirall, Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Additional Files

  • Disclosures

    Files in this Data Supplement:

    • A. Agusti
    • E.D. Bateman
    • C. Caracta
    • F. Chuecos
    • G. de Miquel
    • E. Garcia Gil
    • P.W. Jones
    • R. Lamarca
    • D. Singh
  • Supplementary material

    Please note: supplementary material is not edited by the Editorial Office, and is uploaded as it has been supplied by the author.

    Files in this Data Supplement:

    • Supplementary methods and results - Statistical analyses; Effects of aclidinium on EXACT-identified and HCRU events
    • Supplementary figure S1 - Mean EXACT scores on days -14 to 28
    • Supplementary figure S2 - Numbers of patients with HCRU and/or EXACT-identified events
    • Supplementary table S1 - Comparison of baseline demographics
    • Supplementary table S2 - Comparison of number of EXACT-identified events and HCRU events
    • Supplementary table S3 - Aclidinium treatment differences in SGRQ total score and SGRQ responders
Next
Back to top
Vol 61 Issue 5 Table of Contents
European Respiratory Journal: 61 (5)
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Characterisation and impact of reported and unreported exacerbations: results from ATTAIN
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Characterisation and impact of reported and unreported exacerbations: results from ATTAIN
Paul W. Jones, Rosa Lamarca, Ferran Chuecos, Dave Singh, Alvar Agustí, Eric D. Bateman, Gonzalo de Miquel, Cynthia Caracta, Esther Garcia Gil
European Respiratory Journal Jan 2014, erj00388-2014; DOI: 10.1183/09031936.00038814

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Characterisation and impact of reported and unreported exacerbations: results from ATTAIN
Paul W. Jones, Rosa Lamarca, Ferran Chuecos, Dave Singh, Alvar Agustí, Eric D. Bateman, Gonzalo de Miquel, Cynthia Caracta, Esther Garcia Gil
European Respiratory Journal Jan 2014, erj00388-2014; DOI: 10.1183/09031936.00038814
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Lung volumes and survival in chronic lung allograft dysfunction
  • Aspergillus fumigatus in COPD
  • Calcineurin inhibitors in bronchiolitis obliterans syndrome
Show more Original article

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society